Baillie Gifford & Co
CDLX icon

Baillie Gifford & Co’s Cardlytics CDLX Stock Holding History

Baillie Gifford & Co’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,041
Closed -$187K – 272
2024
Q4 		$187K Sell
5,041
-51,699
-91% -$1.98M ﹤0.01% 256
2024
Q3 		$1.82M Sell
56,740
-26,187
-32% -$1.45M ﹤0.01% 242
2024
Q2 		$6.81M Sell
82,927
-10,982
-12% -$1.19M 0.01% 228
2024
Q1 		$13.6M Sell
93,909
-697
-0.7% -$58.9K 0.01% 207
2023
Q4 		$8.71M Sell
94,606
-10,339
-10% -$1.05M 0.01% 229
2023
Q3 		$17.3M Sell
104,945
-39,119
-27% -$5.08M 0.02% 189
2023
Q2 		$9.1M Buy
144,064
+1,370
+1% +$83K 0.01% 220
2023
Q1 		$4.84M Sell
142,694
-928
-0.6% -$48.5K ﹤0.01% 241
2022
Q4 		$8.3M Buy
143,622
+33,725
+31% +$2.08M 0.01% 230
2022
Q3 		$10.3M Sell
109,897
-4,194
-4% -$597K 0.01% 215
2022
Q2 		$25.5M Buy
114,091
+8,470
+8% +$2.84M 0.03% 184
2022
Q1 		$58.1M Buy
105,621
+13,833
+15% +$8.36M 0.04% 164
2021
Q4 		$60.7M Buy
91,788
+17,208
+23% +$13.2M 0.03% 171
2021
Q3 		$62.6M Buy
74,580
+25,393
+52% +$25.8M 0.03% 172
2021
Q2 		$62.4M Buy
49,187
+4,619
+10% +$5.21M 0.03% 173
2021
Q1 		$48.9M Buy
+44,568
New +$58.8M 0.03% 188

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baillie Gifford & Co's CDLX Position: Q1 2025 in Review

Baillie Gifford & Co sold out of Cardlytics (CDLX) in Q1 2025, closing a stake of 5,041 shares — an estimated $187K sold.

Baillie Gifford & Co first reported a position in CDLX in Q1 2021 and held it in 16 quarters. The position peaked at $62.6M in Q3 2021. 108 funds tracked by Wall St. Rank hold CDLX as of Q1 2025.

  • Baillie Gifford & Co reported no remaining Cardlytics position as of Q1 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 5,041 Cardlytics shares in Q1 2025, an estimated $187K.
  • Baillie Gifford & Co first reported a position in Cardlytics in Q1 2021 and held it in 16 quarters.
  • Baillie Gifford & Co's Cardlytics position peaked at $62.6M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q1 2025.

Based on Baillie Gifford & Co's 13F filing for Q1 2025, filed 7 May 2025.